glp 1 pills fda approved approves first weight-loss GLP-1 pill FDA approves Wegovy weight-loss GLP-1

Research shows that taking 3 g per day for six weeks can saturate keratinocytes in the skin, but taking more does not increase levels and may cause diarrhea

Dambrova M, Makrecka-Kuka M, Kuka J, Vilskersts R, Nordberg D, Attwood MM, et al

Interactions with other diabetes medications: To avoid potential interactions, close monitoring is advised when using tirzepatide alongside other diabetes medications, such as sulfonylureas, SGLT-2 inhibitors, metformin, or insulin

Administration: Typically administered via subcutaneous or slow intravenous injection

Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data